Timothy Eugene Sullivan - Net Worth and Insider Trading
Timothy Eugene Sullivan Net Worth
The estimated net worth of Timothy Eugene Sullivan is at least $4 Million dollars as of 2024-11-05. Timothy Eugene Sullivan is the CFO of Apellis Pharmaceuticals Inc and owns about 149,570 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $4 Million. Details can be seen in Timothy Eugene Sullivan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy Eugene Sullivan has not made any transactions after 2024-04-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy Eugene Sullivan
Timothy Eugene Sullivan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy Eugene Sullivan owns 2 companies in total, including Apellis Pharmaceuticals Inc (APLS) , and G1 Therapeutics Inc (GTHX) .
Click here to see the complete history of Timothy Eugene Sullivan’s form 4 insider trades.
Insider Ownership Summary of Timothy Eugene Sullivan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-04-01 | Chief Financial Officer |
| GTHX | G1 Therapeutics Inc | 2017-05-16 | director |
Timothy Eugene Sullivan Latest Holdings Summary
Timothy Eugene Sullivan currently owns a total of 1 stock. Timothy Eugene Sullivan owns 149,570 shares of Apellis Pharmaceuticals Inc (APLS) as of April 1, 2024, with a value of $4 Million.
Latest Holdings of Timothy Eugene Sullivan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-04-01 | 149,570 | 27.08 | 4,049,608 |
Holding Weightings of Timothy Eugene Sullivan
Timothy Eugene Sullivan Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy Eugene Sullivan has made a total of 8 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 4,000 shares on April 1, 2024, which brought Timothy Eugene Sullivan around $234,640.
Insider Trading History of Timothy Eugene Sullivan
- 1
Timothy Eugene Sullivan Trading Performance
GuruFocus tracks the stock performance after each of Timothy Eugene Sullivan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy Eugene Sullivan is -9.43%. GuruFocus also compares Timothy Eugene Sullivan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy Eugene Sullivan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy Eugene Sullivan's insider trading performs compared to the benchmark.
Performance of Timothy Eugene Sullivan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.69 | | | | | |
| Relative Return to S&P 500(%) | -18.96 | | | | | |
Timothy Eugene Sullivan Ownership Network
Ownership Network List of Timothy Eugene Sullivan
Ownership Network Relation of Timothy Eugene Sullivan
Timothy Eugene Sullivan Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Timothy Eugene Sullivan is the Chief Financial Officer of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Senior Vice President Mark Jeffrey Delong .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Timothy Eugene Sullivan made 8 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 102,839. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 308,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 8,750 shares made by Alec Machiels .
In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,275,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,275,451 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Timothy Eugene Sullivan Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy Eugene Sullivan. You might contact Timothy Eugene Sullivan via mailing address: 800 Boylston St., Suite 3310, Prudential Tower C/o Aju Ib Investment, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
